This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MedCath Sells Louisiana Medical Center & Heart Hospital To Cardiovascular Care Group; Completes Sale Of Hualapai Mountain Medical Center To Kingman Regional Medical Center

CHARLOTTE, N.C., Oct. 3, 2011 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH) announced that it has sold its interest in Louisiana Medical Center & Heart Hospital to Cardiovascular Care Group (CCG).  The purchase agreement and the transaction were simultaneously signed and closed, effective Sept. 30, 2011.

MedCath also announced it has completed the sale of substantially all the assets of Hualapai Mountain Medical Center in Kingman, Ariz., to Kingman Regional Medical Center (KRMC), also effective Sept. 30, 2011.  The transaction was announced in August and was subject to MedCath stockholder approval, which occurred during a Special Meeting of Stockholders on Sept. 22, 2011, as well as other customary closing conditions contained in the Asset Purchase Agreement entered into between the limited liability company that owns Hualapai Mountain Medical Center and KRMC. The transaction was completed in accordance with the terms outlined in MedCath's press release issued August 26, 2011 and Form 8-K filed by MedCath with the Securities and Exchange Commission (the "Commission") on September 1, 2011 together with the additional information provided in the Supplement to Proxy Statement filed with the Commission on September 2, 2011.  

MedCath has now completed 11 transactions since announcing in March 2010 it had formed a Strategic Options Committee to consider the sale either of the entire company or its assets. Earlier this month, MedCath's stockholders approved the proposals contained in a proxy statement filed with the Securities and Exchange Commission on Aug. 17, 2011, authorizing the sale of substantially all the remaining assets of MedCath and the dissolution of the company.

The transaction involving Louisiana Medical Center & Heart Hospital potentially allows the hospital to continue providing high-quality services to St. Tammany Parish and the surrounding areas. It also means local physicians will continue to play a significant role in running the hospital's operations and charting its future direction.

"We're very proud of how Louisiana Medical Center & Heart Hospital has distinguished itself with the quality care it provides," said Art Parker, MedCath's CEO. "It's been named one of the nation's 100 Top Hospitals® for cardiovascular care by Thomson Reuters, it has a patient satisfaction rate of more than 99 percent and it has the best cardiac outcomes of any North Shore hospital. This transaction enables that legacy to continue."

The transaction was structured such that MedCath and CCG simultaneously signed the purchase agreement and closed the transaction. Immediately prior to closing, MedCath converted part of its intercompany loans to the hospital to additional equity in the hospital, increasing MedCath's ownership to 95.4 percent, from 89.2 percent. MedCath then sold its equity and its remaining intercompany loans to CCG for approximately $23.0 million subject to certain working capital adjustments.  MedCath financed CCG's purchase with a seller note that matures 60 days after closing, subject to extension of up to 60 additional days. That 60-day window provides CCG an opportunity to obtain permanent financing of its purchase. The promissory note is secured by the equity in the hospital and the intercompany loans that were sold to CCG, but is otherwise non-recourse to CCG and its affiliates. Upon payment of the promissory note by CCG, MedCath anticipates receiving approximately $33.0 million from the transaction after closing costs, including tax benefits related to the sale. Navigant Capital Advisors provided advisory services to MedCath related to the transaction.

About MedCath

MedCath Corporation, headquartered in Charlotte, N.C., is a health care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates two hospitals with a total of 159 licensed beds, located in California and Texas.

About CCG

Cardiovascular Care Group (CCG) is a physician-driven company that partners with cardiovascular physicians to address the fundamental problems in the delivery of care for patients with cardiovascular disease. CCG, through its affiliates, first began partnering with cardiologists in the ownership of outpatient cardiac catheterization labs in 2000. CCG is headquartered in Nashville, TN.

SOURCE MedCath Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs